# A Study of BMS-562086 in Patients With Irritable Bowel Syndrome

> **NCT00399438** · PHASE2 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 39 (estimated)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** Placebo
- **DRUG:** BMS-562086

## Key facts

- **NCT ID:** NCT00399438
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-10
- **Final completion:** 2008-01
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2008-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00399438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00399438, "A Study of BMS-562086 in Patients With Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00399438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*